FIELD: medicine.
SUBSTANCE: invention describes a gene therapeutic structure coding vascular endothelial growth factor (VEGF) and (FGF-2). Codon-optimised recombinant plasmid lies in the basis of gene therapeutic structure coding both factors. Introduction of gene therapeutic structure may be made directly to a damaged nerve and paraneural tissues both in intraoperative and postpoperative period. The invention may be used for stimulation of nerves regeneration.
EFFECT: invention improves significantly results of reparative treatment for damaged peripheral nerves.
3 cl, 15 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR INDUCTION OF PERIPHERAL NERVE REGENERATION | 2016 |
|
RU2639175C1 |
METHOD FOR STIMULATING NEUROTISATION USING NANOSTRUCTURED MATRIX AND GENETIC CONSTRUCTS | 2012 |
|
RU2517117C2 |
CODON-OPTIMISED SEQUENCES AND PHARMACEUTICAL COMPOSITION FOR RECOVERY OF BLOOD VESSELS | 2014 |
|
RU2557385C1 |
METHOD FOR REPARATIVE ANGIOGENESIS STIMULATION AND CONNECTIVE TISSUE REGENERATION IN CASE OF ITS DAMAGE, BY THE GENETIC THERAPY METHOD USING SPECIES-SPECIFIC VEGF AND FGF2 PROTEIN FACTORS GENES IN VETERINARY MEDICINE, AND GENETIC STRUCTURE FOR IMPLEMENTATION OF METHOD | 2015 |
|
RU2614665C1 |
METHOD FOR GENE THERAPY TREATMENT OF DIABETIC FOOT SYNDROME | 2015 |
|
RU2599507C1 |
AGENT FOR REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN AND METHOD OF CELL-MEDIATED GENE THERAPY FOR ISCHEMIC STROKE OF BRAIN BY REPRESSION OF DEATH OF NEURONS IN ISCHEMIC STROKE OF BRAIN | 2017 |
|
RU2676701C1 |
OPTIMIZED NUCLEOTIDE SEQUENCE AND PHARMACEUTICAL COMPOSITIONS BASED THEREON WITH SUSTAINED VEGF TRANSGENE EXPRESSION | 2015 |
|
RU2612497C2 |
METHOD FOR STIMULATING NEUROGENERATION BY GENETIC MAKE-UPS | 2011 |
|
RU2459630C1 |
METHOD OF STIMULATING REPARATIVE ANGIOGENESIS AND REGENERATION OF SKIN OF DOGS WITH DAMAGE THEREOF BY GENE THERAPY USING SPECIES-SPECIFIC GENES OF PROTEIN FACTORS VEGF AND FGF2 IN VETERINARY SCIENCE AND GENETIC CONSTRUCT FOR REALIZING DECLARED METHOD | 2019 |
|
RU2719513C1 |
METHOD FOR PRODUCING PREPARATION OF GENETICALLY MODIFIED CELLS | 2009 |
|
RU2431669C2 |
Authors
Dates
2015-07-27—Published
2014-09-16—Filed